$BFRI
The ones that got the insider news and got in cheap will dump on the chases.
Biofrontera shares are trading higher after Roth Capital initiated coverage on the stock with a Buy rating and a $20 price target.
Nov 24, 2021 8:14a ETBenzinga
Conversation
Good info. Saw it was running as a low floater, no position. Highly pumped this morning tho
